{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T04:03:55Z","timestamp":1789531435534,"version":"build-2803163510"},"reference-count":56,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,28]],"date-time":"2021-09-28T00:00:00Z","timestamp":1632787200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Pharmaceutica Sinica B"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.apsb.2021.09.027","type":"journal-article","created":{"date-parts":[[2021,9,30]],"date-time":"2021-09-30T15:25:57Z","timestamp":1633015557000},"page":"1351-1362","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"title":["Free energy perturbation (FEP)-guided scaffold hopping"],"prefix":"10.1016","volume":"12","author":[{"given":"Deyan","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuehua","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Runduo","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu-Nian","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-You","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2163-0509","authenticated-orcid":false,"given":"Hai-Bin","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.apsb.2021.09.027_bib1","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.cbpa.2010.02.018","article-title":"Privileged scaffolds for library design and drug discovery","volume":"14","author":"Welsch","year":"2010","journal-title":"Curr Opin Chem Biol"},{"key":"10.1016\/j.apsb.2021.09.027_bib2","doi-asserted-by":"crossref","first-page":"15235","DOI":"10.1021\/acs.chemrev.6b00543","article-title":"Isoxazolidine: a privileged scaffold for organic and medicinal chemistry","volume":"116","author":"Berthet","year":"2016","journal-title":"Chem Rev"},{"key":"10.1016\/j.apsb.2021.09.027_bib3","doi-asserted-by":"crossref","first-page":"7762","DOI":"10.1021\/acs.chemrev.7b00020","article-title":"Chalcone: a privileged structure in medicinal chemistry","volume":"117","author":"Zhuang","year":"2017","journal-title":"Chem Rev"},{"key":"10.1016\/j.apsb.2021.09.027_bib4","doi-asserted-by":"crossref","first-page":"7941","DOI":"10.1021\/acs.jmedchem.6b01720","article-title":"Chromone as a privileged scaffold in drug discovery: recent advances","volume":"60","author":"Reis","year":"2017","journal-title":"J Med Chem"},{"key":"10.1016\/j.apsb.2021.09.027_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cbpa.2018.12.007","article-title":"Natural product derived privileged scaffolds in drug discovery","volume":"52","author":"Davison","year":"2019","journal-title":"Curr Opin Chem Biol"},{"key":"10.1016\/j.apsb.2021.09.027_bib6","doi-asserted-by":"crossref","first-page":"2894","DOI":"10.1002\/(SICI)1521-3773(19991004)38:19<2894::AID-ANIE2894>3.0.CO;2-F","article-title":"\u201dScaffold-hopping\u201d by topological pharmacophore search: a contribution to virtual screening","volume":"38","author":"Schneider","year":"1999","journal-title":"Angew Chem Int Ed"},{"key":"10.1016\/j.apsb.2021.09.027_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.ddtec.2010.09.001","article-title":"The scaffold hopping potential of pharmacophores","volume":"7","author":"Hessler","year":"2010","journal-title":"Drug Discov Today Technol"},{"key":"10.1016\/j.apsb.2021.09.027_bib8","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1021\/jm040163o","article-title":"A shape-based 3-D scaffold hopping method and its application to a bacterial protein\u2212protein interaction","volume":"48","author":"Rush","year":"2005","journal-title":"J Med Chem"},{"key":"10.1016\/j.apsb.2021.09.027_bib9","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1021\/ci900419k","article-title":"Current trends in ligand-based virtual screening: molecular representations, data mining methods, new application areas, and performance evaluation","volume":"50","author":"Geppert","year":"2010","journal-title":"J Chem Inf Model"},{"key":"10.1016\/j.apsb.2021.09.027_bib10","doi-asserted-by":"crossref","first-page":"258","DOI":"10.2174\/092986709787002655","article-title":"Self-organizing maps in drug discovery: compound library design, scaffold-hopping, repurposing","volume":"16","author":"Schneider","year":"2009","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.apsb.2021.09.027_bib11","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.ddtec.2004.10.009","article-title":"Scaffold hopping","volume":"1","author":"B\u00f6hm","year":"2004","journal-title":"Drug Discov Today Technol"},{"key":"10.1016\/j.apsb.2021.09.027_bib12","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1002\/minf.201000019","article-title":"Bioisosteric replacement and scaffold hopping in lead generation and optimization","volume":"29","author":"Langdon","year":"2010","journal-title":"Mol Inform"},{"key":"10.1016\/j.apsb.2021.09.027_bib13","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.drudis.2011.10.024","article-title":"Classification of scaffold-hopping approaches","volume":"17","author":"Sun","year":"2012","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.apsb.2021.09.027_bib14","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1021\/acs.jmedchem.6b01437","article-title":"Recent advances in scaffold hopping: miniperspective","volume":"60","author":"Hu","year":"2017","journal-title":"J Med Chem"},{"key":"10.1016\/j.apsb.2021.09.027_bib15","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1021\/acs.jctc.6b00991","article-title":"Accurate modeling of scaffold hopping transformations in drug discovery","volume":"13","author":"Wang","year":"2017","journal-title":"J Chem Theory Comput"},{"key":"10.1016\/j.apsb.2021.09.027_bib16","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1177\/1753465812463627","article-title":"Tadalafil as monotherapy and in combination regimens for the treatment of pulmonary arterial hypertension","volume":"7","author":"Udeoji","year":"2012","journal-title":"Ther Adv Respir Dis"},{"key":"10.1016\/j.apsb.2021.09.027_bib17","doi-asserted-by":"crossref","first-page":"6622","DOI":"10.1021\/acs.jmedchem.7b00523","article-title":"Discovery and optimization of chromeno[2,3-c]pyrrol-9(2H)-ones as novel selective and orally bioavailable phosphodiesterase 5 inhibitors for the treatment of pulmonary arterial hypertension","volume":"60","author":"Wu","year":"2017","journal-title":"J Med Chem"},{"key":"10.1016\/j.apsb.2021.09.027_bib18","doi-asserted-by":"crossref","first-page":"27381","DOI":"10.1073\/pnas.2010470117","article-title":"Identify potent SARS-CoV-2 main protease inhibitors via accelerated free energy perturbation-based virtual screening of existing drugs","volume":"117","author":"Li","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.apsb.2021.09.027_bib19","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1021\/jm0306430","article-title":"Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy","volume":"47","author":"Friesner","year":"2004","journal-title":"J Med Chem"},{"key":"10.1016\/j.apsb.2021.09.027_bib20","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1021\/jm030644s","article-title":"Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening","volume":"47","author":"Halgren","year":"2004","journal-title":"J Med Chem"},{"key":"10.1016\/j.apsb.2021.09.027_bib21","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1080\/00397919308013802","article-title":"A convenient synthesis of 9-hydroxy-3,4,5,6-tetrahydro-1H-azepino[5,4,3-cd]indole from 7-methoxyindole","volume":"23","author":"Santangelo","year":"1993","journal-title":"Synth Commun"},{"key":"10.1016\/j.apsb.2021.09.027_bib22","doi-asserted-by":"crossref","first-page":"6839","DOI":"10.1016\/j.tet.2013.06.016","article-title":"Highly enantioselective hydrogenation of N-unprotected indoles using (S)-C10\u2013BridgePHOS as the chiral ligand","volume":"69","author":"Li","year":"2013","journal-title":"Tetrahedron"},{"key":"10.1016\/j.apsb.2021.09.027_bib23","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1016\/S0040-4039(01)93730-X","article-title":"The reaction of vinyl\u00a0grignard reagents with 2-substituted nitroarenes: a new approach to the synthesis of 7-substituted indoles","volume":"30","author":"Bartoli","year":"1989","journal-title":"Tetrahedron Lett"},{"key":"10.1016\/j.apsb.2021.09.027_bib24","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1016\/j.bmcl.2011.04.052","article-title":"The discovery and structure\u2013activity relationships of pyrano[3,4-b]indole-based inhibitors of hepatitis C virus NS5B polymerase","volume":"21","author":"Jackson","year":"2011","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.apsb.2021.09.027_bib25","doi-asserted-by":"crossref","first-page":"7264","DOI":"10.1021\/acs.jmedchem.9b00891","article-title":"Discovery of 3,4,6-trisubstituted piperidine derivatives as orally active, low hERG blocking AKT inhibitors via conformational restriction and structure-based design","volume":"62","author":"Dong","year":"2019","journal-title":"J Med Chem"},{"key":"10.1016\/j.apsb.2021.09.027_bib26","doi-asserted-by":"crossref","first-page":"5278","DOI":"10.1016\/j.tet.2009.04.082","article-title":"Diethyl bromodifluoromethylphosphonate: a highly efficient and environmentally benign difluorocarbene precursor","volume":"65","author":"Zafrani","year":"2009","journal-title":"Tetrahedron"},{"key":"10.1016\/j.apsb.2021.09.027_bib27","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1021\/acs.jmedchem.6b01691","article-title":"Difluoromethyl bioisostere: examining the \u201clipophilic hydrogen bond donor\u201d concept","volume":"60","author":"Zafrani","year":"2017","journal-title":"J Med Chem"},{"key":"10.1016\/j.apsb.2021.09.027_bib28","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1080\/00397919108020827","article-title":"The synthesis of 7-alkoxyindoles","volume":"21","author":"Dobson","year":"1991","journal-title":"Synthetic Commun"},{"key":"10.1016\/j.apsb.2021.09.027_bib29","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1023\/A:1008763014207","article-title":"Combined molecular mechanical and continuum solvent approach (MM-PBSA\/GBSA) to predict ligand binding","volume":"18","author":"Massova","year":"2000","journal-title":"Perspect Drug Discovery Des"},{"key":"10.1016\/j.apsb.2021.09.027_bib30","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.bpc.2009.12.007","article-title":"Binding of curcumin with glyoxalase I: molecular docking, molecular dynamics simulations, and kinetics analysis","volume":"147","author":"Liu","year":"2010","journal-title":"Biophys Chem"},{"key":"10.1016\/j.apsb.2021.09.027_bib31","doi-asserted-by":"crossref","first-page":"9478","DOI":"10.1021\/acs.chemrev.9b00055","article-title":"End-point binding free energy calculation with MM\/PBSA and MM\/GBSA: strategies and applications in drug design","volume":"119","author":"Wang","year":"2019","journal-title":"Chem Rev"},{"key":"10.1016\/j.apsb.2021.09.027_bib32","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1021\/ci400063s","article-title":"Identification of novel phosphodiesterase-4D inhibitors prescreened by molecular dynamics-augmented modeling and validated by bioassay","volume":"53","author":"Li","year":"2013","journal-title":"J Chem Inf Model"},{"key":"10.1016\/j.apsb.2021.09.027_bib33","doi-asserted-by":"crossref","first-page":"9537","DOI":"10.1021\/acs.jmedchem.1c00862","article-title":"Discovery of potent phosphodiesterase-9 inhibitors for the treatment of hepatic fibrosis","volume":"64","author":"Wu","year":"2021","journal-title":"J Med Chem"},{"key":"10.1016\/j.apsb.2021.09.027_bib34","doi-asserted-by":"crossref","first-page":"2894","DOI":"10.1111\/j.1743-6109.2011.02382.x","article-title":"Are phosphodiesterase type 5 inhibitors associated with vision-threatening adverse events? A critical analysis and review of the literature","volume":"8","author":"Azzouni","year":"2011","journal-title":"J Sex Med"},{"key":"10.1016\/j.apsb.2021.09.027_bib35","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1002\/med.20053","article-title":"Phosphodiesterase 5 (PDE 5) inhibitors for the treatment of male erectile disorder: attaining selectivity versus PDE6","volume":"26","author":"Pissarnitski","year":"2006","journal-title":"Med Res Rev"},{"key":"10.1016\/j.apsb.2021.09.027_bib36","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/S0006-3495(97)78756-3","article-title":"The statistical-thermodynamic basis for computation of binding affinities: a critical review","volume":"72","author":"Gilson","year":"1997","journal-title":"Biophys J"},{"key":"10.1016\/j.apsb.2021.09.027_bib37","doi-asserted-by":"crossref","first-page":"9535","DOI":"10.1021\/jp0217839","article-title":"Absolute binding free energies: a quantitative approach for their calculation","volume":"107","author":"Boresch","year":"2003","journal-title":"J Phys Chem B"},{"key":"10.1016\/j.apsb.2021.09.027_bib38","doi-asserted-by":"crossref","first-page":"124105","DOI":"10.1063\/1.2978177","article-title":"Statistically optimal analysis of samples from multiple equilibrium states","volume":"129","author":"Shirts","year":"2008","journal-title":"J Chem Phys"},{"key":"10.1016\/j.apsb.2021.09.027_bib39","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1021\/acs.jmedchem.8b01763","article-title":"Absolute binding free energy calculation and design of a subnanomolar inhibitor of phosphodiesterase-10","volume":"62","author":"Li","year":"2019","journal-title":"J Med Chem"},{"key":"10.1016\/j.apsb.2021.09.027_bib40","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/0021-9991(76)90078-4","article-title":"Efficient estimation of free energy differences from Monte Carlo data","volume":"22","author":"Bennett","year":"1976","journal-title":"J Comput Phys"},{"key":"10.1016\/j.apsb.2021.09.027_bib41","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1002\/jcc.20035","article-title":"Development and testing of a general amber force field","volume":"25","author":"Wang","year":"2004","journal-title":"J Comput Chem"},{"key":"10.1016\/j.apsb.2021.09.027_bib42","series-title":"Gaussian 03, revision E.01","author":"Frisch","year":"2004"},{"key":"10.1016\/j.apsb.2021.09.027_bib43","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1002\/jcc.20290","article-title":"The Amber biomolecular simulation programs","volume":"26","author":"Case","year":"2005","journal-title":"J Comput Chem"},{"key":"10.1016\/j.apsb.2021.09.027_bib44","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1063\/1.445869","article-title":"Comparison of simple potential functions for simulating liquid water","volume":"79","author":"Jorgensen","year":"1983","journal-title":"J Chem Phys"},{"key":"10.1016\/j.apsb.2021.09.027_bib45","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1080\/08927028808080941","article-title":"A leap-frog algorithm for stochastic dynamics","volume":"1","author":"Van Gunsteren","year":"1988","journal-title":"Mol Simul"},{"key":"10.1016\/j.apsb.2021.09.027_bib46","doi-asserted-by":"crossref","first-page":"3637","DOI":"10.1021\/ct3000876","article-title":"Efficient algorithms for Langevin and DPD dynamics","volume":"8","author":"Goga","year":"2012","journal-title":"J Chem Theory Comput"},{"key":"10.1016\/j.apsb.2021.09.027_bib47","doi-asserted-by":"crossref","first-page":"234505","DOI":"10.1063\/1.2121687","article-title":"A general purpose model for the condensed\u00a0phases of water: TIP4P\/2005","volume":"123","author":"Abascal","year":"2005","journal-title":"J Chem Phys"},{"key":"10.1016\/j.apsb.2021.09.027_bib48","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1002\/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H","article-title":"LINCS: a linear constraint solver for molecular simulations","volume":"18","author":"Hess","year":"1997","journal-title":"J Comput Chem"},{"key":"10.1016\/j.apsb.2021.09.027_bib49","doi-asserted-by":"crossref","first-page":"8577","DOI":"10.1063\/1.470117","article-title":"A smooth particle mesh Ewald method","volume":"103","author":"Essmann","year":"1995","journal-title":"J Chem Phys"},{"key":"10.1016\/j.apsb.2021.09.027_bib50","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/prot.20033","article-title":"Exploring protein native states and large-scale conformational changes with a modified generalized born model","volume":"55","author":"Onufriev","year":"2004","journal-title":"Protein"},{"key":"10.1016\/j.apsb.2021.09.027_bib51","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/(SICI)1096-987X(19990130)20:2<217::AID-JCC4>3.0.CO;2-A","article-title":"Approximate atomic surfaces from linear combinations of pairwise overlaps (LCPO)","volume":"20","author":"Weiser","year":"1999","journal-title":"J Comput Chem"},{"key":"10.1016\/j.apsb.2021.09.027_bib52","doi-asserted-by":"crossref","first-page":"18680","DOI":"10.1021\/jp063479b","article-title":"How well does Poisson\u2013Boltzmann implicit solvent agree with explicit solvent? A quantitative analysis","volume":"110","author":"Tan","year":"2006","journal-title":"J Phys Chem B"},{"key":"10.1016\/j.apsb.2021.09.027_bib53","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1107\/S0021889883010985","article-title":"Analytical molecular surface calculation","volume":"16","author":"Connolly","year":"1983","journal-title":"J Appl Crystallogr"},{"key":"10.1016\/j.apsb.2021.09.027_bib54","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1021\/ct300418h","article-title":"MMPBSA.py: an efficient program for end-state free energy calculations","volume":"8","author":"Miller","year":"2012","journal-title":"J Chem Theory Comput"},{"key":"10.1016\/j.apsb.2021.09.027_bib55","doi-asserted-by":"crossref","first-page":"9828","DOI":"10.1021\/acs.jmedchem.0c00983","article-title":"Discovery of evodiamine derivatives as highly selective PDE5 inhibitors targeting a unique allosteric pocket","volume":"63","author":"Zhang","year":"2020","journal-title":"J Med Chem"},{"key":"10.1016\/j.apsb.2021.09.027_bib56","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.bcp.2014.02.013","article-title":"Discovery of 3-(4-hydroxybenzyl)-1-(thiophen-2-yl)chromeno[2,3-c]pyrrol-9(2H)-one as a phosphodiesterase-5 inhibitor and its complex crystal structure","volume":"89","author":"Shang","year":"2014","journal-title":"Biochem Pharmacol"}],"container-title":["Acta Pharmaceutica Sinica B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383521003889?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383521003889?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T16:54:11Z","timestamp":1761929651000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211383521003889"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":56,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["S2211383521003889"],"URL":"https:\/\/doi.org\/10.1016\/j.apsb.2021.09.027","relation":{},"ISSN":["2211-3835"],"issn-type":[{"value":"2211-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Free energy perturbation (FEP)-guided scaffold hopping","name":"articletitle","label":"Article Title"},{"value":"Acta Pharmaceutica Sinica B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.apsb.2021.09.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences. Production and hosting by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}